Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1993 | 03-1993 | 12-1992 | 09-1992 | 06-1992 | |
| Sales | 94,436 | 88,940 | 84,353 | 81,861 | 76,327 |
| Cost of Goods | 34,330 | 33,594 | N/A | 29,771 | 28,260 |
| Gross Profit | 60,106 | 55,346 | 84,353 | 52,090 | 48,067 |
| Operating Expenses | 34,190 | 32,343 | 0 | 28,592 | 26,362 |
| Operating Income | 26,246 | 23,597 | 84,353 | 24,269 | 21,965 |
| Interest Expense | 536 | 683 | 0 | 680 | 801 |
| Other Income | 859 | 1,080 | 0 | 1,108 | 193 |
| Pre-tax Income | 26,569 | 23,994 | 84,353 | 24,697 | 21,357 |
| Income Tax | 9,798 | 8,716 | N/A | 9,492 | 8,052 |
| Net Income Continuous | 16,771 | 15,278 | 15,600 | 15,205 | 13,305 |
| Net Income Discontinuous | 0 | 0 | -1,998,000 | -1,998,000 | 0 |
| Net Income | $16,771 | $15,278 | $15,600 | $15,205 | $13,305 |
| EPS Basic Total Ops | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| EPS Basic Continuous Ops | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 |
| EPS Basic Discontinuous Ops | N/A | N/A | -4.90 | -4.91 | N/A |
| EPS Diluted Total Ops | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| EPS Diluted Continuous Ops | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -4.91 | -4.91 | N/A |
| EBITDA(a) | $26,246 | $23,597 | $84,353 | $24,269 | $21,965 |